Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy
- Type
- Retraction
- Notice date
- 2/26/2024 0:00
- Journal
- PLoS One
- Publisher
- PLoS
- Notice DOI
- 10.1371/journal.pone.0299822
- Original paper DOI
- 10.1371/journal.pone.0055790